Holen Sie sich die Stockscreener-App
2.24
1.75%
-0.04
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.04%
41.77
|
50.35 | 57.95 | 57.15 | 42.55 |
| Operating Income/Loss |
17.04%
-41.77
|
-50.35 | -57.95 | -57.15 | -42.55 |
| Nonoperating Income/Loss |
11.05%
3.196
|
3.593 | 3.924 | 3.894 | 3.621 |
| Income/Loss From Continuing Operations Before Tax |
17.44%
-38.57
|
-46.72 | -54.03 | -53.25 | -38.93 |
| Income/Loss From Continuing Operations After Tax |
17.44%
-38.57
|
-46.72 | -54.03 | -53.25 | -38.93 |
|
Net Income/Loss
|
17.50%
-38.57
|
-46.75 | -54.03 | -53.25 | -38.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
34,288%
61.83
|
0.1798 | 58.88 | 58.56 | 57.64 |
| Diluted Average Shares |
34,288%
61.83
|
0.1798 | 58.88 | 58.56 | 57.64 |
| Basic Earnings Per Share |
21.52%
-0.62
|
-0.79 | -0.92 | -0.91 | -0.68 |
| Diluted Earnings Per Share |
21.52%
-0.62
|
-0.79 | -0.92 | -0.91 | -0.68 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):